Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $46.3900 (1.96%) ($45.2400 - $46.5100) on Wed. May. 11, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1% (three month average) | RSI | 87 | Latest Price | $46.3900(1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.6% a day on average for past five trading days. | Weekly Trend | BAX advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(51%) VYM(51%) IVE(49%) IWD(49%) | Factors Impacting BAX price | BAX will decline at least -0.5% in a week (0% probabilities). VIXM(-18%) TLT(-17%) GDXJ(-7%) UUP(-6%) IPO(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.5% (StdDev 1%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
5 Day Moving Average | $45.48(2%) | 10 Day Moving Average | $45.05(2.97%) | 20 Day Moving Average | $44.23(4.88%) | To recent high | 0% | To recent low | 29.3% | Market Cap | $23.667b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |